Ditchcarbon
  • Customers
  1. Organizations
  2. Sinovac Biotech Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 5 months ago

Sinovac Biotech Ltd.

Company website

Sinovac Biotech Ltd., a prominent player in the biopharmaceutical industry, is headquartered in Beijing, China. Founded in 2001, the company has established itself as a leader in the development, manufacture, and commercialisation of vaccines, particularly in the fields of infectious diseases. Sinovac's core products include its inactivated vaccines for hepatitis A, hepatitis B, and influenza, which are distinguished by their rigorous safety and efficacy standards. With a strong presence in Asia and expanding operations globally, Sinovac has achieved significant milestones, including the development of its COVID-19 vaccine, CoronaVac, which has been pivotal in various vaccination campaigns worldwide. The company’s commitment to innovation and public health has solidified its market position, making it a trusted name in vaccine production and distribution.

DitchCarbon Score

How does Sinovac Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Sinovac Biotech Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

14%

Let us know if this data was useful to you

Sinovac Biotech Ltd.'s reported carbon emissions

Sinovac Biotech Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any formal reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate frameworks. While there are no direct emissions reported, it is important to note that Sinovac Biotech Ltd. is part of a broader industry context where many companies are increasingly focusing on sustainability and climate action. The lack of specific emissions data may reflect an opportunity for the company to enhance its climate commitments and transparency. In terms of related entities, Sinova GmbH, a corporate entity within the same family, has shown some engagement with climate initiatives. However, their near-term targets have been classified as "Committed" but lack specific numerical goals. This indicates a potential for future alignment with climate action, although no net-zero commitments have been made. Overall, while Sinovac Biotech Ltd. currently lacks detailed emissions data and formal reduction targets, the evolving landscape of corporate climate responsibility suggests that there may be opportunities for the company to develop and communicate its climate strategy more effectively in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sinovac Biotech Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sinovac Biotech Ltd. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sinovac Biotech Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Serum Institute of India Pvt. Ltd.

IN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Beijing Institute of Biological Products Co., Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bharat Biotech Ltd.

IN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

AstraZeneca AB

SE
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy